{"id":"W2762521795","doi":"10.1200/jco.2017.35.15_suppl.5507","title":"Health-related quality of life (HRQOL) and patient-centered outcomes with maintenance olaparib compared with placebo following chemotherapy in patients with germline (g) BRCA-mutated (m) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): SOLO2 phase III trial.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Placebo; Olaparib; Quality of life (healthcare); Ovarian cancer; Oncology; Adverse effect; Chemotherapy; Clinical endpoint; Cancer; Clinical trial; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001133242,0.0006543208,0.001302899,0.0001905823,0.0001613755,0.0005558411,0.0003829441,0.0005925964,0.00207279],"category_scores_gemma":[0.0008618914,0.0001956051,0.001503056,0.0002663603,0.0003546244,0.0003412882,0.0003163687,0.001546994,0.0002141704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003958642,"about_ca_system_score_gemma":0.0004490341,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003138037,"about_ca_topic_score_gemma":0.0007642308,"domain_scores_codex":[0.9996343,0.0002106299,0.00002101815,0.00005186884,0.00003378165,0.0000485619],"domain_scores_gemma":[0.9995056,0.0001318698,0.000173418,0.00003100354,0.00002050955,0.0001376672],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9242742,0.00680049,0.008269017,0.0007090261,0.002230861,0.0000450891,0.00007690349,0.000890446,0.003558414,0.0001096542,0.0007750987,0.05226082],"study_design_scores_gemma":[0.6264753,0.3191284,0.04503956,0.0001594816,0.002597837,0.0001493984,0.00007485922,0.002226454,0.001882261,0.0003730514,0.001864157,0.00002927227],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943762,0.003677992,0.0001630283,0.0002377741,0.0000804419,0.0003503363,0.0004162275,0.00001677872,0.0006811453],"genre_scores_gemma":[0.9970795,0.0008217072,0.0002988482,0.0002038133,0.00008195604,0.0005106903,0.0005147245,0.000002891226,0.0004858373],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00207279,"threshold_uncertainty_score":0.006934166,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06214157983906568,"score_gpt":0.4178821233779786,"score_spread":0.3557405435389129,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}